ARHGAP29 Is Involved in Increased Invasiveness of Tamoxifen-resistant Breast Cancer Cells and its Expression Levels Correlate With Clinical Tumor Parameters of Breast Cancer Patients.
Kansy M, Wert K, Kolb K, Gallwas J, Gründker C., Free PMC Article

TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.
Jiang X, Du W, Yang C, Wang S, Li Y, Shen X, Yang X, Yao J, Du R, Zhang X, Huang Y, Shen W.

ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.
Shimizu K, Matsumoto H, Hirata H, Ueno K, Samoto M, Mori J, Fujii N, Kawai Y, Inoue R, Yamamoto Y, Yano S, Shimabukuro T, Furutani-Seiki M, Matsuyama H.

Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells.
Kolb K, Hellinger J, Kansy M, Wegwitz F, Bauerschmitz G, Emons G, Gründker C., Free PMC Article

Identification of a Novel Variant of ARHGAP29 in a Chinese Family with Nonsyndromic Cleft Lip and Palate.
Tang JX, Xiao XS, Wang K, Jin JY, Fan LL, Xiang R., Free PMC Article

The SNP rs560426 Within ABCA4-ARHGAP29 Locus and the Risk of Nonsyndromic Oral Clefts.
Wu-Chou YH, Chen KP, Lu YC, Lin YT, Chang HF, Lo LJ.

Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting.
Liu H, Leslie EJ, Carlson JC, Beaty TH, Marazita ML, Lidral AC, Cornell RA., Free PMC Article

Exome sequencing provides additional evidence for the involvement of ARHGAP29 in Mendelian orofacial clefting and extends the phenotypic spectrum to isolated cleft palate.
Liu H, Busch T, Eliason S, Anand D, Bullard S, Gowans LJJ, Nidey N, Petrin A, Augustine-Akpan EA, Saadi I, Dunnwald M, Lachke SA, Zhu Y, Adeyemo A, Amendt B, Roscioli T, Cornell R, Murray J, Butali A., Free PMC Article

YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis.
Qiao Y, Chen J, Lim YB, Finch-Edmondson ML, Seshachalam VP, Qin L, Jiang T, Low BC, Singh H, Lim CT, Sudol M.

Impact of rare variants in ARHGAP29 to the etiology of oral clefts: role of loss-of-function vs missense variants.
Savastano CP, Brito LA, Faria ÁC, Setó-Salvia N, Peskett E, Musso CM, Alvizi L, Ezquina SA, James C, GOSgene, Beales P, Lees M, Moore GE, Stanier P, Passos-Bueno MR.

Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.
Post A, Pannekoek WJ, Ponsioen B, Vliem MJ, Bos JL., Free PMC Article

Further evidence suggesting a role for variation in ARHGAP29 variants in nonsyndromic cleft lip/palate.
Letra A, Maili L, Mulliken JB, Buchanan E, Blanton SH, Hecht JT., Free PMC Article

Digital imaging analysis to assess scar phenotype.
Smith BJ, Nidey N, Miller SF, Moreno Uribe LM, Baum CL, Hamilton GS 3rd, Wehby GL, Dunnwald M., Free PMC Article

Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29.
Post A, Pannekoek WJ, Ross SH, Verlaan I, Brouwer PM, Bos JL., Free PMC Article

Expression and mutation analyses implicate ARHGAP29 as the etiologic gene for the cleft lip with or without cleft palate locus identified by genome-wide association on chromosome 1p22.
Leslie EJ, Mansilla MA, Biggs LC, Schuette K, Bullard S, Cooper M, Dunnwald M, Lidral AC, Marazita ML, Beaty TH, Murray JC., Free PMC Article

Mutation of ARHGAP9 in patients with coronary spastic angina.
Takefuji M, Asano H, Mori K, Amano M, Kato K, Watanabe T, Morita Y, Katsumi A, Itoh T, Takenawa T, Hirashiki A, Izawa H, Nagata K, Hirayama H, Takatsu F, Naoe T, Yokota M, Kaibuchi K.

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T, von Neuhoff N, Kamphues K, Emura M, Lehmann U, Tauscher M, Schraders M, Groenen P, Skawran B, Rudolph C, Callet-Bauchu E, van Krieken JH, Schlegelberger B, Steinemann D.